SCHEMBL4996449

SCHEMBL4996449

C[C@H](NOc1cc2ccccc2o1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
MAOB P27338 4/20 0.47
MAOA P21397 1/20 0.47
LMNA P02545 1/20 0.46
THRB P10828 1/20 0.46
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HPGD P15428 1/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
MAPT P10636 2/20 0.42
TP53 P04637 2/20 0.42
CASP3 P42574 1/20 0.42
SENP7 Q9BQF6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL456821 0.76 ALDH1A1 (0.62) ALDH1A1MAOBMAOALMNATHRB
SCHEMBL456822 0.76 ALDH1A1 (0.62) ALDH1A1MAOBMAOALMNATHRB
Hydrochloric Acid SCHEMBL1116447 0.75 ALDH1A1 (0.61) ALDH1A1MAOBMAOALMNATHRB
SCHEMBL6607462 0.74 ALDH1A1 (0.53) ALDH1A1MAOBMAOALMNANPC1
SCHEMBL26668782 0.74 NPC1 (0.54) ALDH1A1MAOBNPC1RAB9AMEN1
SCHEMBL7150833 0.73 PPARG (0.50) NPC1RAB9AMEN1KMT2ACYP1A2
SCHEMBL28275043 0.72 ALDH1A1 (1.00) ALDH1A1LMNATHRBNPC1RAB9A
SCHEMBL28275041 0.72 ALDH1A1 (1.00) ALDH1A1LMNATHRBNPC1RAB9A
SCHEMBL4200612 0.72 FLT3 (0.52) ALDH1A1MAOBMAOANPC1RAB9A
SCHEMBL10326014 0.71 MTNR1B (0.42) LMNAMEN1KMT2ACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214660-A1 Compounds and Methods for the Inhibition of the Expression of VCAM-1 CRABTREE ACQUISITION CO, LLC 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214660-A1 Compounds and Methods for the Inhibition of the Expression of VCAM-1 VCAM1, ICAM1, SELL ALDH1A1 100/4885MAOB 1411/4885MAOA 1896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.